poisar

Stocks · News reference

Benchmark Initiates Coverage On Inflection Point Acq with Buy Rating, Announces Price Target of $14

BenzingaAug 4, 2026, 11:44 AMBenzinga Newsdesk

Benchmark analyst Subash Chandra initiates coverage on Inflection Point Acq (NASDAQ:IPEX) with a Buy rating and announces Price Target of $14.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 4, 2026, 11:44 AM
Checked
Aug 4, 2026, 11:44 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaJun 11, 2026, 12:00 PMNa

    GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Public Filing of Amendment No. 1 to the Registration Statement on Form F-4 in Connection with Proposed Business Combination

    GOWell Technology Limited and Inflection Point Acquisition Corp. V (NASDAQ: IPEX) have filed Amendment No. 1 to their joint Form F-4 registration statement with the SEC regarding their proposed business combination. Upon closing, the combined company will operate as GOWell Energy Technology and trade on Nasdaq under ticker symbol 'GOW'. The business combination is expected to close in summer 2026, subject to regulatory and stockholder approvals.

    Read original at benzinga